Submissions

Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • Manuscript (MS document)
  • Manuscript for Reviewer
  • Certification of proofread
  • Checklist before submitting manuscript to Siriraj Medical Journal
  • Letter of Certification before Publishing Article(s) in Siriraj Medical Journal (SMJ)
  • IRB approval, coi disclosure, consent form and/or clinical trial registration are required.
  • A cover letter
  • Proof of plagiarism check with %Turnitin <20
  • Illustrations should be saved at the highest resolution setting and sized no larger than 800 kB per file as possible.
    Figure images should be provided in JPEG or TIF format.
  • Diagrams, charts, graphs or tables (NOT exceed 6 in total) should be created and included in MS Word (Submission files). Authors should NOT attach them as pictures in the files.

Author Guidelines

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. Manuscript
  2. Manuscript for Reviewer
  3. Certification of English proofread by a native English speaker
  4. Checklist before submit the article to Siriraj Medical Journal
  5. Letter of Certification before Publishing Article(s) in Siriraj Medical Journal (SMJ)
  6. IRB approval, ICMJE Conflict of Interest form, consent form and clinical trial registration are required.
  7. A cover letter It is recommended to state that written permission to publish case details or use photographs of unavoidably identifiable persons has been obtained.
  8. Plagiarism report Articles must be checked for potential plagiarism with %Turnitin <20%.
  9. Illustrations / figures of the highest resolution provided in JPEG format
  10. Diagrams, charts, graphs or tables (NOT exceed 6 in total) should be created and included in MS Word (Manuscript). Authors are not recommended to attach them as pictures in the files.

 

Formatting manuscript

The manuscript should be presented in the following order: 

Title page: The title page should contain the following:

  • Title of the paper.
  • A short running head (no more than 50 characters, including spaces).
  • Type of manuscript (e.g. Original Article, Review Article).
  • Full names of all authors with the highest academic degree.
  • Addresses of the institutions at which the work was carried out.
  • E-mail address and telephone numbers, of the author to whom correspondence about the manuscript, proofs, and requests for offprint should be sent.
  • Conflict of interest statement
  • A declaration of clinical trial approval

 

Abstract: An abstract, no longer than 250 words or less. The abstract should state the Objective, Materials and Methods, Results, and Conclusion, each with a brief adequate presentation.

Keywords: Keywords are the words that describe your topic of research. These can be individual words or a phrase. These keywords can be chosen from the sentence you create to define your research topic. 

Types of Articles:

  • Original Article: Original articles should be written and structured by four main sections: Introduction/Objectives, Materials and Methods, Results, and Discussion/Conclusion. The manuscript length, excluding references, should not exceed 3,500 words. Tables and figures/ illustrations should not exceed 6 in total.
  • Review Article: The manuscript length, excluding references, should not exceed 4,500 words. Tables and illustrations should not exceed 8 in total.
  • Letter to the Editor: The manuscript length, excluding references, should not exceed 2,500 words.

References: The Vancouver system of referencing should be used. References should be cited numerically in the order they appear in the text. Identify references in text, tables, and legends by Arabic numerals in superscripts. In the reference list, the references should be numbered and listed in order of appearance in the text.
           Cite the names of all authors when there are six or fewer; when there are seven or more, list the first six followed by “et al”. 

  • Journal article
    Sibai BM. Magnesium sulfate is the ideal anticonvulsant in preeclampsia-eclampsia. Am J Obstet Gynecol 1990;162:1141-5.
  • Books
    Remington JS, Swartz MN. Current Topics in Infectious Diseases, Vol 21. Boston: Blackwell Science Publication, 2001.
  • Chapter in a Book
    Cunningham FG, Hauth JC, Leveno KJ, Gilstrap L III, Bloom SL, Wenstrom KD. Hypertensive disorders in pregnancy. In: Cunningham FG, Hauth JC, Leveno KJ, Gilstrap L III, Brom SL, Wenstrom KD, eds. Williams Obstetrics, 22nd ed. New York: McGraw-Hill, 2005.p.761-808. 

Original Article

Original articles are characterized by their systematic approach to presenting methods, results, and discussions.  The manuscript length, excluding references, should not exceed 3,500 words. Tables and figures/ illustrations should not exceed 6 in total.

Review Article

A review article provides an exhaustive synopsis of research on a particular subject or offers a panoramic overview of existing research on a specific topic. The manuscript length, excluding references, should not exceed 4,500 words. Tables and illustrations should not exceed 8 in total

Letter to the Editor

Letters to the editors are concise communications that offer readers the opportunity to express their opinions or provide insights on previously published articles. These letters can contribute to ongoing discussions or provide additional perspectives on a topic. While brief, letters to the editor should maintain scholarly rigor and contribute to the dynamic. The manuscript length, excluding references, should not exceed 2,500 words.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.